Humanized anti-IgE antibodies that crosslink CD23 on B lymphocytes but do not sensitize mast cells
A novel humanized anti-IgE antibody is disclosed. The antibody is capable of binding to free IgE, membrane-bound IgE on B lymphocytes, IgE bound by CD23, but not to IgE bound by high-affinity IgE.Fc receptor on mast cells. The present invention relates to the treatment of IgE-mediated diseases, including allergic asthma, allergic rhinitis, atopic dermatitis, food allergy, chronic spontaneous (idiopathic) urticaria, chronic rhinosinusitis, systemic mastocytosis, cutaneous mastocytosis, allergic bronchopulmonary aspergillosis, recurrent idiopathic angioedema, and eosinophil-associated gastrointestinal disorder by administering the anti-IgE antibody of the present invention.
C A C C A C A C C A A C A C A
C07K A61P C07K C07K A61P C07K A61P C07K C07K A61K A61P C07K A61P C07K A61P
additional inventional additional additional inventional additional inventional inventional additional additional inventional additional inventional inventional inventional
Jiun-Bo Tse-Wen Yu-Yu
Chen Chang Shiung